| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Adaptive Biotechnologies targets 30%+ clonoSEQ test volume growth in 2026 while expanding margins and data partnerships | ||
| Fr | Newell Brands outlines 2026 EPS guidance of $0.54-$0.60 and targets operating margin expansion amid productivity plan | ||
| Fr | Canopy Growth signals positive adjusted EBITDA in fiscal 2027 amid MTL acquisition and expanding European focus | ||
| Fr | AGC Inc. GAAP EPS of ¥325.67, revenue of ¥2058.8B | ||
| Fr | Compass said to have lost bid to halt part of Zillow's listing ban policy | ||
| Fr | Dynatrace Q3 2026 Earnings Preview | ||
| Fr | Coty outlines targeted turnaround in Consumer Beauty through streamlined innovation and SKU focus | ||
| Fr | Cleveland-Cliffs Q4 2025 Earnings Preview | ||
| Fr | Becton, Dickinson Q1 2026 Earnings Preview | ||
| Fr | FinecoBank Banca Fineco S.p.A. reports FY 2025 results | ||
| Fr | Apollo Global Management Q4 2025 Earnings Preview | ||
| Fr | PepsiCo extends rally for a seventh straight session | ||
| Fr | PowerFleet Q3 2026 Earnings Preview | ||
| Fr | TPG to acquire majority stake in Sabre Industries from Blackstone | ||
| Fr | Silver's 'gamma squeezes' are over for now - analyst | ||
| Fr | Crypto-linked stocks rebound as bitcoin, ether rout ease | ||
| Fr | Komercní banka, a.s. reports Q4 2025 results | ||
| Fr | RXO outlines $5M-$12M Q1 2026 EBITDA outlook as cost actions and AI investments continue | ||
| Fr | Valmet Oyj GAAP EPS of €1.52, revenue of €5.2B | ||
| Fr | GSK wins EU nod to expand Nucala for COPD | ||
| Fr | Banco de Sabadell, S.A. reports Q4 2025 results | ||
| Fr | Nvidia leads chip stocks higher as broader market gains after software sell-off | ||
| Fr | I3 Verticals targets double-digit recurring revenue growth for FY 2026 as SaaS momentum accelerates | ||
| Fr | Strattec outlines $3.4M annualized savings from restructuring while advancing gross margin goals | ||
| Fr | UK regulator warns of rare vision loss risk with Novo's Ozempic, Wegovy |